Dr. Anderson, in partnership with her colleague, Vanessa Adams, served as the U.S. D&I leads for the Employee Resource Group (ERG) Capitol Hill Fly-In. They worked to produce content, align with ERG associates for the opportunity and partnered with Public Affairs to execute the initiative. The Fly-in provided Novartis associates who participate in ERGs with
As assistant director of marketing operations in Northbrook, Illinois, John invests considerable time and energy encouraging employee participation in initiatives focused on constructive public policies that help foster medical innovation and help provide patient access to needed medicines. John helped create Astellas’ civic engagement program that enables colleagues to voluntarily reach out to elected officials
With years of experience in both pharmaceuticals and digital medicine, Rohit is driving Otsuka’s launch strategy to bring prescription digital therapeutics to patients suffering from serious mental illness. His work has propelled Otsuka as a driver of legislation around creating a benefit category and reimbursement paradigm for PDTs.
Saloni’s work brought the first-ever approved treatment to address symptoms of agitation associated with dementia due to Alzheimer’s disease. She has also engaged with members of Congress and administration staff to help drive awareness of the disease. Additionally, she has advocated for policy changes that are reflective of the evolving treatment landscape.
Brendan actively engages with external stakeholders to support our industry and demonstrate the value of our medicines to policymakers. He has educated state legislators on the drug supply chain and value-based insurance designs so that legislators have the knowledge to make informed decisions about legislation seeking to ensure patient access to affordable medicines.
Bob is an effective and accessible voice in highlighting the value of the pharmaceutical industry for policymakers and thought leaders. He has engaged federal, state and local officials at the site to help them better understand the challenges and opportunities of our industry. Bob is also involved and supportive of Pfizer’s Michigan Legislative Leaders program,
Phil is the Head of Chemistry and Pharmaceutical Sciences at Sunovion, but he also takes the time to participate in “State Researcher Fly-In Days.” Before these events, he takes the time to research the legislators he will meet and then develops the key points for each meeting. His research experience has impacted multiple meetings in
Jason Brandt is highly committed to civic action both personally and professionally. Through his role on the Sanofi US PAC Board, Jason advocates tirelessly for issues related to the healthcare industry. His passion for civic action is also clearly apparent in his leadership role as a Vice President of Sales in our Diabetes and Cardiovascular,
Oleg is a special type of researcher who can translate scientific concepts into themes and messages that resonate with non-scientists. He communicates the value of the critical work of pharmaceutical research in understandable, impactful ways to key elected officials, advocates and the public visiting Pfizer’s La Jolla, California site for many years now. Additionally, he
(Merck) – Steve advocates for the key role that pharmaceuticals play in the overall treatment of disease, where his goal is to drive business strategy and project planning. He has led the way for Merck to have significant process efficiencies, year over year cost reductions, working capital improvements, better value and innovation.